O2h Ventures

Type

Venture Capital

Status

Active

Location

Cambridge, United Kingdom

Total investments

37

Average round size

3M

Portfolio companies

28

Lead investments

12

Follow on index

0.24

Exits

2

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareArtificial IntelligenceHealth CareHealth DiagnosticsDeliveryMedicalLife SciencePharmaceuticalBiopharma

Summary

O2h Ventures appeared to be the VC, which was created in 2003.

The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 51 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this O2h Ventures works on 15 percentage points less the average amount of lead investments.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the O2h Ventures, startups are often financed by Innovate UK, Angel CoFund, Wellcome Trust. The meaningful sponsors for the fund in investment in the same round are Oxford Investment Opportunity Network, Esther Dyson, Delin Ventures. In the next rounds fund is usually obtained by Department of Health and Social Care (DHSC).

The fund was created by Sunil Shah.

The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Oxford Drug Design, Exonate. Among the most popular fund investment industries, there are Software, SaaS. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesAI/Big Data
Stage focus
Series ASeries B
Geo focus
United Kingdom

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
37
Lead investments
12
Exits
2
Follow on index
0.24
Investments by industry
  • Biotechnology (26)
  • Health Care (17)
  • Pharmaceutical (11)
  • Biopharma (9)
  • Artificial Intelligence (5)
  • Show 16 more
Investments by region
  • United Kingdom (33)
  • Hungary (3)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Group Appearance index
0.70
Avg. company exit year
16

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cortirio 15 Oct 2020 Health Care, Medical Device Seed England, London, United Kingdom
Turbine 07 Jan 2021 Biotechnology, Artificial Intelligence, Biopharma Seed 6M Budapest, Hungary
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.